Prospective multicenter study to measure the impact of MMprofiler on treatment intention in active multiple myeloma patients
Sponsor: |
SkylineDx, Inc. |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAR4254 |
U.S. Govt. ID: |
NCT02911571 |
Contact: |
Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu |
We are doing this study to learn if the MMprofiler test can help your doctor in making decisions about your treatment. The MMprofiler genomic test will look at a large number of normal genes. The test will predict risk of your multiple myeloma (MM) by assessing whether these genes are turned on or off in your cancer cells. The purpose of this research is to study whether this test can help your doctor to determine what treatment will be best for your multiple myeloma.
This study is closed
Investigator
Suzanne Lentzsch, MD
Are you 18 years or older? |
Yes |
No |
Do you have potentially active/active multiple myeloma? |
Yes |
No |